EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Second Quarter Financial Results on Wednesday, August 9
August 01, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
EC-Logo-2018_TM_CMYK.jpg
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
July 18, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
July 13, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
EC-Logo-2018_TM_CMYK.jpg
electroCore Provides Select Second Quarter 2023 Financial Guidance
July 11, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary...